Low and therapeutic doses of antidepressants are associated with similar response in the context of multimodal treatment of pain

Pain Physician

Volumn 12, Issue 5, 2009, Pages 893-900

  Bajwa, Zahid H ^a,b   Simopoulos, Thomas T ^b   Pal, Joshua ^b   Kraemer, Jan J ^b   Chopra, Pradeep ^b   Nagda, Jyotsna ^b   Najib, Umer ^a   Celestin, James ^a   Sial, Khuram ^b   Ahmad, Bilal ^b   Warfield, Carol ^b   Steinman, Theodore I ^a   Wootton, Joshua ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Chronic pain; Multidisciplinary pain center; Multimodal analgesia

Indexed keywords

AMFEBUTAMONE; AMINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; CHRONIC PAIN; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG RESPONSE; DRUG UTILIZATION; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYALGIA; NEUROPATHIC PAIN; NUMERICAL RATING PAIN SCALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRESCRIPTION; RADICULAR PAIN; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PAIN CLINICS; PAIN MEASUREMENT; PAIN THRESHOLD; PATIENT CARE TEAM; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449719339     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Kuhn R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry 1958; 115:459-464.
2. Paoli F, Darcourt G, Corsa P. Note prèliminaire sur l'action de l'imipramine dans les ètats douloures. Revue de Neurologie 1960; 2:503-504.
3. Watson CP. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994; 6:392-405.
4. Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964; 1:1235-1238.
5. Bouckoms AJ, Hackett TP. Pain patients. In: Cassem NH (ed). Massachusetts General Hospital Handbook of General Hospital Psychiatry. 4th ed. St. Louis: Mosby-Yearbook, 1997; p 367-413.
6. Hyman SE, Cassem NH. Pain. In: Dale DC, Federman DD (eds). Scientific American Medicine. New York: Scientific American, 1994; p 1-18.
7. Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965;150:971-979
8. Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. JAMA 1984; 251:1727-1730. (Pubitemid 14174179)
9. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987; 37:589-596. (Pubitemid 17057933)
10. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R. Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial. Pain 1991; 45:3-9.
11. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326:1250-1256.
12. Sindrup SH, Ejlersten B, Froland A, Sindrup EH, Brosen K, Gram LF. Imipramine treatment in diabetic neuropathy: Relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol 1989; 37:151-153. (Pubitemid 19215454)
13. Sindrup SH, Gram LF, Skjold T, Froland A, Beck-Nielsen H. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990; 47:509-515. (Pubitemid 20151477)
14. Max MB, Shafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline but not lorazepam relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1988; 38:1427-1432.
15. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith I, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32:671-673.
16. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: A randomized, double-blind, crossover trial. Pain 1992; 48:29-36.
17. Leijon G, Boivie J. Central post-stroke pain: A controlled trial of amitriptyline and carbamazepine. Pain 1989;3 6:27-36. (Pubitemid 19024963)
18. Hirsch M, Birnbaum, RJ. Pharmacology and use of antidepressants. Up To Date 2004; 12.2:10-19.
19. Horst WD, Preskorn SH. Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, bupropion. J Affect Disord 1998; 51:237-254.
20. Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: A review of current literature. Harvard Rev Psychiatry 2000; 7:257-277. (Pubitemid 30051667)
21. Saper JR, Silberstein SD, Lake AE III, Winters ME. Double-blind trial of fluoxetine: Chronic daily headache and migraine. Headache 1994; 34:497-502.
22. Saper JR, Silberstein SD, Lake AE III, Winters ME. Fluoxetine and migraine: Comparison of double-blind trials [Letter]. Headache 1995; 35:233.
23. Markeley HG, Gasser PA, Markley ME, Pratt SM. Fluoxetine in prophylaxis of headache: Clinical experience. Cephalalgia 1991; 11(suppl 11):164-165.
24. Sosin D. Clinical efficacy of fluoxetine vs. sertraline in a headache clinic population [Abstract]. Headache 1993; 33:284.
25. Richeimer SH, Bajwa ZH, Kahraman SS, Ransil BJ, Warfield C. Utilization patters of tricyclic antidepressants in multidisciplinary pain clinic: A survey. The Clinical Journal of Pain 1997; 13:324-329. (Pubitemid 28028097)
26. Richelson E. Antidepressants: Pharmacology and clinical use. American Psychiatric Association Task Force on Treatments of Psychiatric Disorders. Washington D.C.: American Psychiatric Association, 1989; 3:1773-1786.
27. Danish University Antidepressant Group. Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Dis 1990; 18:289-299.
28. Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB. Single doses of the serotonin-agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 1989; 37:223-227. (Pubitemid 19136151)
29. Goldenberg D, Mayskiy M, Mossey C, uthazer R, Schmid C. A randomized, double-blind crossover trail of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-1859. (Pubitemid 26378576)
30. Goodnick PJ, Jimenez I, Kumar A. Sertraline in diabetic neuropathy: Preliminary results. Ann Clin Psychiatry 1997; 9:255-257. (Pubitemid 28122131)
31. Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992; 32:101-104.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, revised 3rd ed. Washington D.C.: American Psychiatric Association; 1987.
33. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003; 163:2716-2724.
34. Kadiroglu AK, Sit D, Kayabasi H, Tuzcu AK, Tasdemir N, Yilmaz ME. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications 2008; 22:241-245. (Pubitemid 351885487)
35. Zissis NP, Harmoussi S, Vlaikidis N, Mitsikostas D, Thomaidis T, Georgiadis G, Karageorgiou K. A randomized, double- blind, placebo-controlled study of venlafaxine XR in out-patients with tension- type headache. Cephalalgia.2007; 27:315-324. (Pubitemid 46434967)
36. Jann MW, Slade JH. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 2007; 27:1571-1587. (Pubitemid 350060211)
37. Freynhagen R, Muth-Selbach U, Lipfert P, Stevens, MF, Zacharowski K, Tölle TR, von Giesen H-J. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin 2006; 22:257-264. (Pubitemid 44296749)
38. Samborski W, Lezanska-Szpera M, Rybakowski JK. Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 2004; 37:168-170. (Pubitemid 38916425)
39. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004; 62:1706-1711. (Pubitemid 38661723)
40. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 2001; 57:1583-1588. (Pubitemid 33055474)
41. Semenchuk MR, Davis B. Efficacy of sustained-release bupropion in neuropathic pain: An open-label study. Clin J Pain 2000; 16:6-11. (Pubitemid 30155389)